instruction stringlengths 225 2.35k | input stringlengths 89 1.5k | response stringclasses 698 values |
|---|---|---|
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
B: anthreptes
C: bacillus toyonensis biovar thuringiensis
D: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
E: anthrenus
F: bacillus anthracis ames "ancestor" (aka bacillus anthracis str. 'ames ancestor')
G: mycobacterium anthracenicum ('mycobacterium anthracenicum') (aka mycobacterium anthracenicum)
H: anthrax bacterium (aka bacillus anthracis)
I: lycoriella thuringiensis
J: bacillus cereus group sp.
K: anthrax irroratus
L: bacillus cereus group
M: bacillus anthracis ames (aka bacillus anthracis str. ames)
N: anthrax
O: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
P: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
Q: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
R: cereus (aka cereus <eudicots>)
S: chromobacterium group
T: None of the above. | [L; H; H; A] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: bacillus anthracis str. ames ancestor (aka bacillus anthracis str. 'ames ancestor')
B: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
C: bacillus cereus group
D: cereus (aka cereus <sea anemones>)
E: bacillus/clostridium group (aka bacillota)
F: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
G: anthrenus
H: anthracus
I: bacillus thuringiensis gv. thuringiensis
J: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
K: anthrax (aka bacillus anthracis)
L: bacillus thuringiensis serovar thailandensis
M: anthrax varius
N: chromobacterium group
O: bacillus mojavensis subgroup
P: anthrax
Q: bacillus cereus biovar anthracis
R: anthriscus
S: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
T: None of the above. | [C; K; K; S] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bacillus cereus group; b. anthracis; anthrax; b. thuringiensis]
<Options>: A: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
B: bacillus thuringiensis gv. cytolyticus
C: bacillus anthracis (strain ames) (aka bacillus anthracis str. ames)
D: bacillus mojavensis subgroup
E: bacillus subtilis group
F: anthrax
G: bacillus cereus biovar anthracis
H: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
I: anthrenus
J: anthribola
K: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
L: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
M: anthribus
N: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
O: bacillus thuringiensis serovar brasilensis (bacillus thuringiensis serovar brasiliensis) (aka bacillus thuringiensis serovar brasilensis)
P: lycoriella thuringiensis
Q: bacillus cereus var. anthracis (aka bacillus anthracis)
R: bacillus cereus group
S: None of the above. | [R; Q; Q; H] |
<Instruct>: Given the context 'Abstract
The Bacillus cereus group of bacteria is an important group including mammalian and insect pathogens, such as B. anthracis, the anthrax bacterium, B. thuringiensis, used as a biological pesticide and B. cereus, often involved in food poisoning incidents.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus]
<Options>: A: bacillus endorhythmos (aka bacillus cereus)
B: vibrio subtilis (aka bacillus subtilis)
C: bacillus cereus group
D: bacillus cereus str. w (aka bacillus cereus w)
E: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
F: None of the above. | [A] |
<Instruct>: Given the context 'Therefore, we have developed a database that compiles and integrates MLST data from all five schemes for the B. cereus group, accessible at http://mlstoslo.uio.no/. Supertree techniques were used to combine the phylogenetic information from analysis of all schemes and datasets, in order to produce an integrated view of the B. cereus group population.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
B: bacillus subtilis group sp.
C: bacillus sp. (in: firmicutes)
D: bacillus cereus group
E: cereus (aka cereus <sea anemones>)
F: None of the above. | [D] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: streptococcus parasuis
B: haemophilus sp.
C: streptococcus
D: neisseria meningitidis group b (aka neisseria meningitidis serogroup b)
E: streptococcus pyogenes (streptococcus erysipelatos) (aka streptococcus pyogenes)
F: haemophilus ducreyi (aka [haemophilus] ducreyi)
G: streptococcus uberis
H: haemophilus parahaemolyticus
I: neisseria lactamicus (aka neisseria lactamica)
J: streptococcus infantis
K: neisseria meningitidis str. nmb (aka neisseria meningitidis nmb)
L: micrococcus pneumoniae (aka streptococcus pneumoniae)
M: micrococcus meningitidis (aka neisseria meningitidis)
N: streptococcus suis
O: micrococcus gonorrhoeae (aka neisseria gonorrhoeae)
P: haemophilus taxon c (haemophilus sp. (strain taxon c)) (aka haemophilus taxon c)
Q: influenza-bacillus (aka haemophilus influenzae)
R: streptococcus sanguinis
S: None of the above. | [M; L; E; Q] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: micrococcus pneumoniae (aka streptococcus pneumoniae)
B: streptococcus uberis
C: streptococcus erysipelatos (aka streptococcus pyogenes)
D: neisseria meningitidis serogroup y
E: haemophilus
F: haemophilus somnifer (aka histophilus somni)
G: neisseria meningitidis serogroup a (neisseria meningitidis (serogroup a)) (aka neisseria meningitidis serogroup a)
H: mycobacterium influenzae (aka haemophilus influenzae)
I: haemophilus parahaemolyticus
J: haemophilus haemoglobinophilus (aka canicola haemoglobinophilus)
K: streptococcus pyogenes (streptococcus erysipelatos) (aka streptococcus pyogenes)
L: staphylococcus pyogenes aureus (aka staphylococcus aureus)
M: streptococcus infantis
N: neisseria meningitidis str. nmb (aka neisseria meningitidis nmb)
O: micrococcus meningitidis cerebrospinalis (aka neisseria meningitidis)
P: streptococcus parasuis
Q: bacillus pneumoniae (aka klebsiella pneumoniae)
R: 'streptococcus pasteuri' (aka streptococcus pasteuri)
S: streptococcus sp. (group b) (aka streptococcus sp. 'group b')
T: neisseriaceae bacterium
U: None of the above. | [O; A; C; H] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: haemophilus taxon c (haemophilus sp. (strain taxon c)) (aka haemophilus taxon c)
B: haemophilus ducreyi (aka [haemophilus] ducreyi)
C: streptococcus ovis
D: neisseriaceae bacterium
E: streptococcus pseudopneumoniae
F: streptococcus suis
G: streptococcus gallolyticus subsp. pasteurianus (aka streptococcus pasteurianus)
H: 'streptococcus pasteuri' (aka streptococcus pasteuri)
I: neisseria meningitidis (micrococcus meningitidis cerebrospinalis) (aka neisseria meningitidis)
J: gonococcus neisseri (aka neisseria gonorrhoeae)
K: haemophilus meningitidis (aka haemophilus influenzae)
L: micrococcus pneumoniae (aka streptococcus pneumoniae)
M: streptococcus pyogenes (streptococcus erysipelatos) (aka streptococcus pyogenes)
N: haemophilus parahaemolyticus
O: streptococcus parapneumoniae
P: neisseria meningitidis str. nmb (aka neisseria meningitidis nmb)
Q: neisseria meningitidis (serogroup a) (aka neisseria meningitidis serogroup a)
R: haemophilus haemoglobinophilus (aka canicola haemoglobinophilus)
S: streptococcus mitis
T: streptococcus infantis
U: None of the above. | [I; L; M; K] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neisseria meningitidis; streptococcus pneumoniae; streptococcus pyogenes; haemophilus influenzae]
<Options>: A: streptococcus sanguinis
B: neisseria meningitidis (serogroup c) (aka neisseria meningitidis serogroup c)
C: neisseria meningitidis strain nmb (aka neisseria meningitidis nmb)
D: haemobacillus
E: streptococcus pasteuri ('streptococcus pasteuri') (aka streptococcus pasteuri)
F: streptococcus parasuis
G: haemophilus haemolyticus (bacillus x) (aka haemophilus haemolyticus)
H: neisseria meningitidis serogroup z
I: histophilus somni (haemophilus somnifer) (aka histophilus somni)
J: streptococcus pyogenes (streptococcus erysipelatos) (aka streptococcus pyogenes)
K: gonococcus neisseri (aka neisseria gonorrhoeae)
L: diplococcus pneumoniae (aka streptococcus pneumoniae)
M: streptococcus mutans
N: streptococcus parapneumoniae
O: haemophilus influenzae (haemophilus meningitidis) (aka haemophilus influenzae)
P: haemophilus sp.
Q: micrococcus meningitidis cerebrospinalis (aka neisseria meningitidis)
R: pneumovirus
S: streptococcus
T: None of the above. | [Q; L; J; O] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: campylobacter sp.
B: campylobacter fetus subsp. jejuni (aka campylobacter jejuni)
C: enterococcus faecium (streptococcus faecium) (aka enterococcus faecium)
D: burkholderia pseudomallei (loefflerella pseudomallei) (aka burkholderia pseudomallei)
E: campylobacter coli (campylobacter hyoilei) (aka campylobacter coli)
F: enterococcus proteiformis (aka enterococcus faecalis)
G: campylobacter jejuni-like bacterium
H: staphylococcus sp.
I: enterococcus faecium ef_aus0080
J: micrococcus pyogenes (aka staphylococcus aureus)
K: staphylococcus aureus pa (staphylococcus aureus strain pa) (aka staphylococcus aureus pa)
L: enterococcus faecium ef_aus0050
M: campylobacter jejuni x
N: burkholderia pseudomallei b03
O: burkholderia pseudomallei strain os (aka burkholderia pseudomallei os)
P: aurococcus (aka staphylococcus)
Q: staphylococcus aureus subsp. aureus col (staphylococcus aureus col) (aka staphylococcus aureus subsp. aureus col)
R: burkholderia pseudomallei bdu 2
S: streptococcus faecium var. casseliflavus (aka enterococcus casseliflavus)
T: burkholderia pseudomallei dl2
U: None of the above. | [J; B; C; D] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: staphylococcus aureus subsp. aureus col (staphylococcus aureus col) (aka staphylococcus aureus subsp. aureus col)
B: campylobacter
C: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
D: enterococcus faecium (streptococcus faecium) (aka enterococcus faecium)
E: enterococcus faecium ef_aus0065
F: burkholderia pseudomallei dl2
G: staphylococcus epidermidis (staphylococcus epidermidis albus) (aka staphylococcus epidermidis)
H: campylobacter jejuni subsp. jejuni 1798
I: staphylococcus group (aka staphylococcaceae)
J: enterococcus faecium ef_aus0051
K: bacterium whitmori (aka burkholderia pseudomallei)
L: enterococcus casseliflavus (streptococcus faecium subsp. casseliflavus) (aka enterococcus casseliflavus)
M: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
N: campylobacter jejuni (campylobacter fetus subsp. jejuni) (aka campylobacter jejuni)
O: campylobacter gastrosuis
P: burkholderia pseudomallei 6(1960)
Q: campylobacter hominis (candidatus campylobacter hominis) (aka campylobacter hominis)
R: micrococcus aureus (aka staphylococcus aureus)
S: enterococcus faecium e155
T: staphylococcus simulans staphylolyticus (aka staphylococcus simulans bv. staphylolyticus)
U: None of the above. | [R; N; D; K] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: enterococcus faecium ef_aus0029
B: 'staphylococcus faecalis' (aka staphylococcus faecalis)
C: enterococcus faecium ef_aus0021
D: staphylococcus epidermidis (staphylococcus epidermidis albus) (aka staphylococcus epidermidis)
E: campylobacter sp.
F: streptococcus faecium var. casseliflavus (aka enterococcus casseliflavus)
G: burkholderia pseudomallei b03
H: campylobacter gastrosuis
I: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
J: streptococcus faecium (aka enterococcus faecium)
K: staphylococcus aureus str. pa (aka staphylococcus aureus pa)
L: campylobacter hominis (candidatus campylobacter hominis) (aka campylobacter hominis)
M: campylobacter jejuni-like bacterium
N: vibrio jejuni (aka campylobacter jejuni)
O: burkholderia pseudomallei dl2
P: staphylococcus sp.
Q: enterococcus faecium ef_aus0055
R: burkholderia pseudomallei 6(1960)
S: micrococcus aureus (aka staphylococcus aureus)
T: loefflerella pseudomallei (aka burkholderia pseudomallei)
U: None of the above. | [S; N; J; T] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [staphylococcus aureus; campylobacter jejuni; enterococcus faecium; burkholderia pseudomallei]
<Options>: A: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
B: enterococcus
C: staphylococcus epidermidis (staphylococcus epidermidis albus) (aka staphylococcus epidermidis)
D: staphylococcus simulans staphylolyticus (aka staphylococcus simulans bv. staphylolyticus)
E: campylobacter-like bacterium
F: streptococcus faecium (aka enterococcus faecium)
G: staphylococcus faecalis ('staphylococcus faecalis') (aka staphylococcus faecalis)
H: enterococcus plantarum
I: staphylococcus aureus pa (staphylococcus aureus strain pa) (aka staphylococcus aureus pa)
J: burkholderia pseudomallei (loefflerella pseudomallei) (aka burkholderia pseudomallei)
K: enterococcus faecium ef_aus0095
L: campylobacter jejuni (campylobacter fetus subsp. jejuni) (aka campylobacter jejuni)
M: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
N: enterococcus faecium ef_aus0065
O: campylobacter gastrosuis
P: campylobacter sp.
Q: campylobacter jejuni subsp. jejuni str. nw (aka campylobacter jejuni subsp. jejuni nw)
R: burkholderia pseudomallei (ara+ biotype) (burkholderia siamensis) (aka burkholderia pseudomallei (ara+ biotype))
S: micrococcus aureus (aka staphylococcus aureus)
T: burkholderia thailandensis (burkholderia pseudomallei-like species) (aka burkholderia thailandensis)
U: None of the above. | [S; L; F; J] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [escherichia coli; salmonella enterica; bacillus cereus group]
<Options>: A: bacillus/lactobacillus/streptococcus group (aka bacilli)
B: e. coli (aka escherichia coli)
C: salmonella cholerae-suis (aka salmonella enterica)
D: cereus (aka cereus <eudicots>)
E: bacillus cereus group
F: salmonella enterica serovar gallinarum (aka salmonella enterica subsp. enterica serovar gallinarum)
G: escherichia sp.
H: unspecified coliform bacterium
I: enterobacteriales (aka enterobacterales)
J: bacillus sp. (in: firmicutes)
K: chromobacterium group
L: escherichia coli b (escherichia coli (strain b)) (aka escherichia coli b)
M: salmonella enterica serovar choleraesuis (aka salmonella enterica subsp. enterica serovar choleraesuis)
N: salmonella enteritidis (aka salmonella enterica subsp. enterica serovar enteritidis)
O: salmonella enterica subsp. enterica serovar abortus (salmonella abortus) (aka salmonella enterica subsp. enterica serovar abortus)
P: None of the above. | [B; C; E] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [escherichia coli; salmonella enterica; bacillus cereus group]
<Options>: A: salmonella enterica subsp. enterica (salmonella cholerae-suis subsp. cholerae-suis) (aka salmonella enterica subsp. enterica)
B: bacillus mojavensis subgroup
C: salmonella
D: bacillus sp. (in: firmicutes)
E: salmonella enterica serovar typhimurium (aka salmonella enterica subsp. enterica serovar typhimurium)
F: escherichia coli 1a
G: bacterium coli (aka escherichia coli)
H: enterobacteriaceae bacterium
I: bacteria (ex cavalier-smith 1987) (aka bacteria)
J: bacillus enteritidis (aka salmonella enterica subsp. enterica serovar enteritidis)
K: bacillus cereus group
L: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
M: salmonella enterica (salmonella enterica ser. choleraesuis) (aka salmonella enterica)
N: escherichia sp.
O: cereus (aka cereus <eudicots>)
P: None of the above. | [G; M; K] |
<Instruct>: Given the context 'Since the initial development of this technique for Neisseria meningitidis in 1998, MLST schemes have been developed for about 30 species including some of the most important bacterial pathogens, e.g. Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus, Campylobacter jejuni, Enterococcus faecium, Burkholderia pseudomallei, Escherichia coli, Salmonella enterica and the Bacillus cereus group (see (1) for a recent review).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [escherichia coli; salmonella enterica; bacillus cereus group]
<Options>: A: chromobacterium group
B: salmonella enterica subsp. enterica serovar abortus (salmonella abortus) (aka salmonella enterica subsp. enterica serovar abortus)
C: enterococcus coli (aka escherichia coli)
D: escherichia coli 1a
E: bacteria (ex cavalier-smith 1987) (aka bacteria)
F: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
G: salmonella typhimurium (aka salmonella enterica subsp. enterica serovar typhimurium)
H: escherichia coli b (escherichia coli (strain b)) (aka escherichia coli b)
I: salmonella sp.
J: unclassified bacillus cereus group
K: salmonella enterica subsp. enterica serovar enteritidis (salmonella enterica serovar enteritidis) (aka salmonella enterica subsp. enterica serovar enteritidis)
L: salmonella enterica (salmonella enterica ser. choleraesuis) (aka salmonella enterica)
M: escherichia faecalis ('escherichia faecalis') (aka escherichia faecalis)
N: bacillus subtilis group
O: bacillus cereus group
P: None of the above. | [C; L; O] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacteridium anthracis (aka bacillus anthracis)
B: bacillus cereus group
C: anthreptes
D: limnophora anthrax (aka spilogona anthrax)
E: mycobacterium anthracenicum ('mycobacterium anthracenicum') (aka mycobacterium anthracenicum)
F: bacillus cereus strain f (aka bacillus cereus f)
G: cereus (aka cereus <eudicots>)
H: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
I: anthrax subgroup
J: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
K: bacillus subtilis group
L: bacillus cereus biovar anthracis
M: platypeza anthrax
N: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
O: chromobacterium group
P: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
Q: None of the above. | [B; A; A; H] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus mojavensis subgroup
B: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
C: cereus <eudicots> (cereus) (aka cereus <eudicots>)
D: bacillus cereus group
E: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
F: bacillus cereus group sp.
G: unclassified anthrax
H: bacillus/clostridium group (aka bacillota)
I: anthrax bacterium (aka bacillus anthracis)
J: bacillus anthracis (strain ames) (aka bacillus anthracis str. ames)
K: anthrenus
L: anthrax subgroup
M: anthrax anthrax (musca anthrax) (aka anthrax anthrax)
N: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
O: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
P: bacillus cereus biovar anthracis
Q: bacillus anthracis str. ames ancestor (aka bacillus anthracis str. 'ames ancestor')
R: None of the above. | [D; I; I; O] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: anthracus
B: anthrenus
C: bacillus anthracis strain 'ames ancestor' (aka bacillus anthracis str. 'ames ancestor')
D: bacillus cereus group
E: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
F: bacillus subtilis group
G: vibrio subtilis (aka bacillus subtilis)
H: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
I: bacillus anthracis ames (aka bacillus anthracis str. ames)
J: pseudolithoxus anthrax (lasiancistrus anthrax) (aka pseudolithoxus anthrax)
K: cereus (aka cereus <sea anemones>)
L: bacillus/clostridium group (aka bacillota)
M: anthrax subgroup
N: bacillus cereus biovar anthracis
O: unclassified anthrax
P: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
Q: anthrax (aka bacillus anthracis)
R: None of the above. | [D; Q; Q; H] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus cereus str. w (aka bacillus cereus w)
B: bacillus sp. (in: firmicutes)
C: bacillus anthracis ames (aka bacillus anthracis str. ames)
D: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
E: bacillus anthracis (strain sterne) (aka bacillus anthracis str. sterne)
F: bacillus cereus strain f (aka bacillus cereus f)
G: bacillus cereus group sp.
H: anthrax (aka bacillus anthracis)
I: cereus (aka cereus <eudicots>)
J: anthribola
K: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
L: anthrax
M: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
N: unclassified bacillus cereus group
O: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
P: pseudolithoxus anthrax (lasiancistrus anthrax) (aka pseudolithoxus anthrax)
Q: bacillus cereus group
R: anthribus
S: anthrax subgroup
T: None of the above. | [Q; H; H; M] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group; b. anthracis; anthrax; b. cereus]
<Options>: A: bacillus cereus strain f (aka bacillus cereus f)
B: anthribus
C: anthribola
D: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
E: pseudolithoxus anthrax (lasiancistrus anthrax) (aka pseudolithoxus anthrax)
F: bacillus cereus group
G: bacillus cereus str. w (aka bacillus cereus w)
H: cereus (aka cereus <eudicots>)
I: bacillus anthracis ames (aka bacillus anthracis str. ames)
J: bacillus anthracis (strain sterne) (aka bacillus anthracis str. sterne)
K: bacillus sp. (in: firmicutes)
L: anthrax
M: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
N: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
O: bacillus cereus group sp.
P: unclassified bacillus cereus group
Q: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
R: anthrax subgroup
S: None of the above. | [F; S; S; N] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus weihenstephanensis dsm 11821 (aka bacillus mycoides nbrc 101238 = dsm 11821)
B: macrobiotus sapiens
C: bacillus weihenstephanensis (aka bacillus mycoides)
D: birds (aka aves)
E: bacillus weihaiensis
F: lycoriella thuringiensis
G: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
H: listeria weihenstephanensis (paenilisteria weihenstephanensis) (aka listeria weihenstephanensis)
I: probles
J: luteimonas weifangensis (aka cognatiluteimonas weifangensis)
K: homo sapiens (human) (aka homo sapiens)
L: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
M: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
N: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
O: primate (aka primates)
P: None of the above. | [K; G; C] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus thuringiensis gv. cytolyticus
B: listeria weihenstephanensis (paenilisteria weihenstephanensis) (aka listeria weihenstephanensis)
C: bacillus weihenstephanensis (aka bacillus mycoides)
D: probles
E: avian (aka aves)
F: bacillus weihenstephanensis dsm 11821 (aka bacillus mycoides nbrc 101238 = dsm 11821)
G: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
H: human (aka homo sapiens)
I: placental mammals (aka eutheria)
J: bacillus thuringiensis gv. thuringiensis
K: bacillus thuringiensis serovar kurstaki (bacillus thuringiensis (subsp. kurstaki)) (aka bacillus thuringiensis serovar kurstaki)
L: bacillus weihaiensis
M: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
N: pseudomonas weihenstephanensis
O: macrobiotus sapiens
P: None of the above. | [H; M; C] |
<Instruct>: Given the context 'The B. cereus group includes bacterial species that are of medical and/or economic importance, such as B. anthracis, an obligate mammalian pathogen causing the lethal disease anthrax, B. cereus, an opportunistic human pathogen involved in food-poisoning incidents and contaminations in hospitals, B. thuringiensis, an insect pathogen and one of the world's most widely used biopesticide and B. weihenstephanensis, a cold-tolerant species known for contaminating dairies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; b. thuringiensis; b. weihenstephanensis]
<Options>: A: birds (aka aves)
B: bacillus weihaiensis
C: pseudomonas weihenstephanensis
D: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
E: animals (aka metazoa)
F: stegana weiqiuzhangi
G: bacillus thuringiensis serovar thailandensis
H: henneguya weishanensis
I: bacillus thuringiensis gv. thuringiensis
J: this
K: homo sapiens (human) (aka homo sapiens)
L: bacillus weihenstephanensis (aka bacillus mycoides)
M: bacillus thuringiensis subsp. thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
N: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
O: macrobiotus sapiens
P: None of the above. | [K; D; L] |
<Instruct>: Given the context 'Unlike other bacterial species that are typed using a single MLST scheme, five separate schemes have been developed for the B. cereus group, based on different sets of genes and isolates (5–10).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus subtilis group
B: bacillus/clostridium group (aka bacillota)
C: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
D: bacillus subtilis group sp.
E: bacillus cereus group
F: None of the above. | [E] |
<Instruct>: Given the context 'Unlike other bacterial species that are typed using a single MLST scheme, five separate schemes have been developed for the B. cereus group, based on different sets of genes and isolates (5–10).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus/clostridium group (aka bacillota)
B: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
C: bacillus subtilis group sp.
D: bacillus subtilis group
E: None of the above. | [E] |
<Instruct>: Given the context 'Studies with the various schemes have independently indicated that the B. cereus group population is divided into three main phylogenetic clusters and that species are usually intermixed within the groups.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus <eudicots> (cereus) (aka cereus <eudicots>)
B: chromobacterium group
C: bacillus cereus group
D: bacillus/clostridium group (aka bacillota)
E: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
F: None of the above. | [C] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: bacteridium anthracis (aka bacillus anthracis)
B: anthracus
C: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
D: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
E: bacillus thuringiensis gv. thuringiensis
F: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
G: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
H: bacillus thuringiensis kurstaki (aka bacillus thuringiensis serovar kurstaki)
I: bacillus anthracis (strain sterne) (aka bacillus anthracis str. sterne)
J: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
K: bacillus cereus var. anthracis (aka bacillus anthracis)
L: bacillus endorhythmos (aka bacillus cereus)
M: bacillus cereus strain atcc 10987 (aka bacillus cereus atcc 10987)
N: bacillus toyonensis biovar thuringiensis
O: anthrax
P: None of the above. | [A; L; D] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
B: bacillus anthracis ames "ancestor" (aka bacillus anthracis str. 'ames ancestor')
C: bacillus thuringiensis gv. cytolyticus
D: bacillus thuringiensis serovar thuringiensis (bacillus thuringiensis subsp. thuringiensis) (aka bacillus thuringiensis serovar thuringiensis)
E: bacillus cereus group
F: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
G: anthrax
H: cereus (aka cereus <eudicots>)
I: bacillus cereus biovar anthracis
J: vibrio subtilis (aka bacillus subtilis)
K: anthracus
L: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
M: bacillus toyonensis biovar thuringiensis
N: anthrax bacterium (aka bacillus anthracis)
O: bacillus thuringiensis gv. thuringiensis
P: None of the above. | [N; L; F] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: bacillus cereus var. anthracis (aka bacillus anthracis)
B: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: bacillus toyonensis biovar thuringiensis
E: anthrax (aka bacillus anthracis)
F: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
G: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
H: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
I: bacillus cereus str. w (aka bacillus cereus w)
J: bacillus thuringiensis serovar thailandensis
K: anthracus
L: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
M: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
N: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
O: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
P: None of the above. | [E; C; B] |
<Instruct>: Given the context 'One cluster contains the monomorphic B. anthracis isolates and a number of B. cereus and B. thuringiensis strains, many of which are from clinical sources.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis; b. cereus; b. thuringiensis]
<Options>: A: bacillus cereus str. w (aka bacillus cereus w)
B: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
C: bacillus cereus var. anthracis (aka bacillus anthracis)
D: bacillus thuringiensis serovar thailandensis
E: bacillus anthracis bf1 (aka bacillus anthracis str. bf1)
F: bacillus cereus f (bacillus cereus strain f) (aka bacillus cereus f)
G: bacillus anthracis sterne (aka bacillus anthracis str. sterne)
H: bacillus toyonensis biovar thuringiensis
I: 'mycobacterium anthracenicum' (aka mycobacterium anthracenicum)
J: bacillus thuringiensis serovar nigeriensis (bacillus thuringiensis subsp. nigeriensis) (aka bacillus thuringiensis serovar nigeriensis)
K: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
L: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
M: bacillus wiedmannii biovar thuringiensis (aka bacillus wiedmannii bv. thuringiensis)
N: anthracus
O: None of the above. | [O; L; K] |
<Instruct>: Given the context 'A second heterogeneous cluster includes B. cereus and B. thuringiensis isolates from various origins, while cold-tolerant B. weihenstephanensis and B. cereus isolates belong to the third group.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus thuringiensis (bacillus thuringiensis berliner 1915 (approved lists 1980)) (aka bacillus thuringiensis)
B: bacillus weihenstephanensis dsm 11821 (aka bacillus mycoides nbrc 101238 = dsm 11821)
C: bacillus endorhythmos (aka bacillus cereus)
D: bacillus thuringiensis serovar thailandensis
E: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
F: bacillus thuringiensis subsp. nigeriensis (aka bacillus thuringiensis serovar nigeriensis)
G: bacillus anthracis (bacillus cereus var. anthracis) (aka bacillus anthracis)
H: bacillus weihenstephanensis (aka bacillus mycoides)
I: bacillus cereus biovar anthracis
J: bacillus cereus str. w (aka bacillus cereus w)
K: bacillus weihaiensis
L: bacillus toyonensis biovar thuringiensis
M: spongicoloides weijiaensis
N: bacillus thuringiensis subsp. wuhanensis (aka bacillus thuringiensis serovar wuhanensis)
O: bacillus thuringiensis serovar kurstaki (bacillus thuringiensis (subsp. kurstaki)) (aka bacillus thuringiensis serovar kurstaki)
P: None of the above. | [C; A; H] |
<Instruct>: Given the context 'A second heterogeneous cluster includes B. cereus and B. thuringiensis isolates from various origins, while cold-tolerant B. weihenstephanensis and B. cereus isolates belong to the third group.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus; b. thuringiensis; b. weihenstephanensis]
<Options>: A: cereus (aka cereus <sea anemones>)
B: bacillus cereus str. w (aka bacillus cereus w)
C: bacillus thuringiensis serovar thailandensis
D: bacillus weihenstephanensis (aka bacillus mycoides)
E: bacillus thuringiensis wuhanensis (aka bacillus thuringiensis serovar wuhanensis)
F: cereus (aka cereus <eudicots>)
G: bacillus thuringiensis subsp. thuringiensis (aka bacillus thuringiensis serovar thuringiensis)
H: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
I: bacillus wiedmannii bv. thuringiensis (bacillus wiedmannii biovar thuringiensis) (aka bacillus wiedmannii bv. thuringiensis)
J: bacillus thuringiensis berliner 1915 (approved lists 1980) (aka bacillus thuringiensis)
K: luteimonas weifangensis (aka cognatiluteimonas weifangensis)
L: henneguya weishanensis
M: bacillus endorhythmos (aka bacillus cereus)
N: bacillus weihenstephanensis dsm 11821 (aka bacillus mycoides nbrc 101238 = dsm 11821)
O: lycoriella thuringiensis
P: None of the above. | [M; J; D] |
<Instruct>: Given the context 'A second heterogeneous cluster includes B. cereus and B. thuringiensis isolates from various origins, while cold-tolerant B. weihenstephanensis and B. cereus isolates belong to the third group.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus; b. thuringiensis; b. weihenstephanensis]
<Options>: A: bacillus cereus var. thuringiensis (aka bacillus thuringiensis)
B: paenilisteria weihenstephanensis (aka listeria weihenstephanensis)
C: bacillus thuringiensis gv. thuringiensis
D: alsophila weidenbrueckiae (alsophila weidenbrueckii) (aka alsophila weidenbrueckiae)
E: bacillus cereus var. anthracis (aka bacillus anthracis)
F: bacillus thuringiensis serovar brasiliensis (aka bacillus thuringiensis serovar brasilensis)
G: bacillus weihaiensis
H: bacillus weihenstephanensis (aka bacillus mycoides)
I: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
J: bacillus thuringiensis serovar thailandensis
K: bacillus thuringiensis gv. cytolyticus
L: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
M: spongicoloides weijiaensis
N: bacillus cereus group
O: None of the above. | [I; A; H] |
<Instruct>: Given the context 'The separate MLST analyses have also revealed that the B. cereus group population is weakly clonal overall due to numerous clinical and virulent isolates emerging from different phylogenetic positions (5–8,11–14), with the exception of the ‘cold-tolerant’ cluster that seems to exhibit a panmictic (or sexual) population structure, i.e. with frequent genetic exchanges between strains (9).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group
B: bacillus/clostridium group (aka bacillota)
C: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
D: bacillus subtilis group
E: bacillus mojavensis subgroup
F: None of the above. | [A] |
<Instruct>: Given the context 'The separate MLST analyses have also revealed that the B. cereus group population is weakly clonal overall due to numerous clinical and virulent isolates emerging from different phylogenetic positions (5–8,11–14), with the exception of the ‘cold-tolerant’ cluster that seems to exhibit a panmictic (or sexual) population structure, i.e. with frequent genetic exchanges between strains (9).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus subtilis group
B: bacillus mojavensis subgroup
C: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
D: bacillus/clostridium group (aka bacillota)
E: None of the above. | [E] |
<Instruct>: Given the context 'Here, in order to provide the B. cereus group research community with a common MLST resource, we have developed on the same website a database, SuperCAT, that compiles and integrates MLST data from all the published B. cereus group schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group
B: bacillus cereus group sp.
C: bacillus subtilis group sp.
D: cereus <eudicots> (cereus) (aka cereus <eudicots>)
E: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
F: None of the above. | [A] |
<Instruct>: Given the context 'In addition, we applied supertree reconstruction methods to build an integrated view of the B. cereus group population and phylogeny.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group
B: bacillus cereus group sp.
C: bacillus subtilis group
D: bacillus mojavensis subgroup
E: cereus (aka cereus <sea anemones>)
F: None of the above. | [A] |
<Instruct>: Given the context 'The SuperCAT database provides information, sequence and phylogenetic data for all bacterial isolates that have been typed using any of the five published MLST schemes for the B. cereus group (Table 1).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus <eudicots> (cereus) (aka cereus <eudicots>)
B: bacillus cereus group
C: unclassified bacillus cereus group
D: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
E: bacillus mojavensis subgroup
F: None of the above. | [B] |
<Instruct>: Given the context 'SuperCAT also contains the phylogenetic supertree of the B. cereus group reconstructed by combining the sequence data from all five schemes, as well as supertrees built for individual schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus mojavensis subgroup
B: bacillus/clostridium group (aka bacillota)
C: chromobacterium group
D: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
E: bacillus cereus group
F: None of the above. | [E] |
<Instruct>: Given the context 'In addition, sequences of all MLST loci were extracted from the complete genomes of the 21 sequenced B. cereus group strains available in Genbank.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus (aka cereus <sea anemones>)
B: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
C: bacillus subtilis group sp.
D: chromobacterium group
E: bacillus cereus group
F: None of the above. | [E] |
<Instruct>: Given the context 'Table 1.The five MLST schemes designed for typing bacteria of the B. cereus groupSchemeGenesTotal sequence length (bp)Total number of isolateseUsed in (references)Helgasonadk, ccpA, ftsA, glpT, pyre, recF and sucC2 938120(6,12,46)Candelon–Sorokina,cclpC, dinB, gdpD, panC, purF and yhfL2 850149(9,10)Kob,cgyrB, mbl, mdh, mutS, pycA(1) and rpoB2 00265(7)Priesta,bglpF, gmk, ilvD, pta, purH, pycA(2) and tpi2 829721(8,11,13–15,46–48)Tourasse–Helgasona,b,dadk, ccpA, glpF, glpT, panC, pta and pycA(2)2 658172(5)aSpecific databases for the Priest and Tourasse–Helgason schemes are accessible at http://pubmlst.org/bcereus/ and http://mlstoslo.uio.no/, respectively.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
B: chromobacterium group
C: cereus <eudicots> (cereus) (aka cereus <eudicots>)
D: bacillus cereus group
E: bacillus subtilis group
F: None of the above. | [D] |
<Instruct>: Given the context 'A BLAST database for the Candelon–Sorokin scheme is available at http://spock.jouy.inra.fr/cgi-bin/bacilliMLSopen.cgi.bWhile the Tourasse–Helgason and Priest schemes use the same gene fragment for the pycA gene, the Ko scheme is based on a different and non-overlapping gene region.cThe B. cereus group-specific transcriptional regulator plcR was originally included in the Candelon–Sorokin and Ko schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group sp.
B: bacillus cereus group
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: cereus (aka cereus <eudicots>)
E: unclassified bacillus cereus group
F: None of the above. | [B] |
<Instruct>: Given the context 'In this study, the 21 B. cereus group strains that have been completely sequenced, and for which the sequences at all 26 MLST loci are thus available, can be used to join all five schemes and provide the strain overlap necessary for supertree analysis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus <eudicots> (cereus) (aka cereus <eudicots>)
B: bacillus cereus group
C: bacillus subtilis group
D: bacillus cereus str. f (aka bacillus cereus f)
E: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
F: None of the above. | [B] |
<Instruct>: Given the context 'The global B. cereus group supertree, containing 1029 isolates, was reconstructed according to the widely used matrix representation by parsimony (MRP) procedure (Figure 1; (19,25,26)).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group sp.
B: bacillus subtilis group
C: unclassified bacillus cereus group
D: bacillus cereus group
E: bacillus sp. (in: firmicutes)
F: None of the above. | [D] |
<Instruct>: Given the context 'Figure 1.Schematic overview of the B. cereus group supertree reconstruction procedure using Matrix Representation by Parsimony (MRP).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus <eudicots> (cereus) (aka cereus <eudicots>)
B: bacillus cereus group
C: bacillus cereus group sp.
D: bacillus mojavensis subgroup
E: bacillus subtilis group sp.
F: None of the above. | [B] |
<Instruct>: Given the context 'Figure 1.Schematic overview of the B. cereus group supertree reconstruction procedure using Matrix Representation by Parsimony (MRP).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus mojavensis subgroup
B: bacillus cereus group sp.
C: bacillus subtilis group sp.
D: cereus <eudicots> (cereus) (aka cereus <eudicots>)
E: None of the above. | [E] |
<Instruct>: Given the context 'It should be noted that the global 1029-strain supertree retains the phylogenetic signals from the individual schemes and contains the three main clusters of the B. cereus group population described in the section ‘Introduction’.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: cereus (aka cereus <eudicots>)
B: unclassified bacillus cereus group
C: bacillus cereus group
D: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
E: bacillus/clostridium group (aka bacillota)
F: None of the above. | [C] |
<Instruct>: Given the context 'These 21 isolates cover all three clusters, although the majority of them are B. anthracis strains or clinical strains closely related to B. anthracis due to the focus of genome sequencing projects, making the part of the supertree containing these isolates likely to be more accurate than the rest of the tree.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. anthracis]
<Options>: A: bacteridium anthracis (aka bacillus anthracis)
B: bacillus cereus biovar anthracis ci (aka bacillus cereus biovar anthracis str. ci)
C: anthracus
D: bacillus cereus biovar anthracis
E: bacillus anthracis str. ames ancestor (aka bacillus anthracis str. 'ames ancestor')
F: None of the above. | [A] |
<Instruct>: Given the context 'Precise within-cluster groupings may contain more uncertainty, as indicated by the large number of unresolved multifurcations in the B. cereus group supertree.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group sp.
B: cereus (aka cereus <eudicots>)
C: bacillus amyloliquefaciens group (operational group b. amyloliquefaciens) (aka bacillus amyloliquefaciens group)
D: bacillus/clostridium group (aka bacillota)
E: bacillus cereus group
F: None of the above. | [E] |
<Instruct>: Given the context 'Apart from the basic functions for selecting and accessing strain information and sequence data for all five B. cereus group MLST schemes, the main features of SuperCAT relate to the manipulation of the supertrees constructed by the MRP approach.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
B: bacillus cereus group sp.
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: bacillus subtilis group
E: bacillus cereus group
F: None of the above. | [E] |
<Instruct>: Given the context 'The global supertree based on the combination of all five B. cereus group MLST schemes as well as the five scheme-specific supertrees can be browsed according to various user-chosen criteria (Figure 2).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
B: bacillus subtilis group
C: bacillus cereus group
D: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
E: bacillus sp. (in: firmicutes)
F: None of the above. | [C] |
<Instruct>: Given the context 'DISCUSSION AND FUTURE DEVELOPMENTS
SuperCAT is a newly created database devoted to the B. cereus group of bacteria whose main objectives are to provide a common MLST repository and means for building a comprehensive genetic analysis of the group that has been typed by five separate schemes.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus subtilis group
B: bacillus cereus group
C: cereus <sea anemones> (cereus) (aka cereus <sea anemones>)
D: bacillus sp. (in: firmicutes)
E: bacillus/clostridium group (aka bacillota)
F: None of the above. | [B] |
<Instruct>: Given the context 'In particular, a new improved method has recently been developed for taking into account both nucleotide substitutions and recombination events in phylogenies, as part of the ClonalFrame software, which has been applied to the B. cereus group and the Priest scheme (38).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus mojavensis subgroup
B: cereus (aka cereus <sea anemones>)
C: bacillus cereus (bacillus cereus frankland and frankland 1887 (approved lists 1980)) (aka bacillus cereus)
D: bacillus cereus group
E: bacillus cereus group sp.
F: None of the above. | [D] |
<Instruct>: Given the context 'As MLEE, AFLP and MLST have different levels of resolution, one can hope that combining them might provide an even more robust supertree for the B. cereus group.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. cereus group]
<Options>: A: bacillus cereus group
B: bacillus subtilis group
C: bacillus cereus frankland and frankland 1887 (approved lists 1980) (aka bacillus cereus)
D: chromobacterium group
E: bacillus <firmicutes> (bacillus rrna group 1) (aka bacillus <firmicutes>)
F: None of the above. | [A] |
<Instruct>: Given the context 'RESULTS AND DISCUSSION Potential cytotoxic activity of synthesized fused isoxazolines 1 and 2 was tested in vitro on four monolayer tumor cell lines: MG-22A (mouse hepatoma), HT-1080 (human fibroblastoma), B16 (mouse melanoma), Neuro 2A (mouse neiroblastoma).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse; human]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: human (aka homo sapiens)
C: mouse (aka mus musculus)
D: homo (humans) (aka homo)
E: mus sp. (mice (aka mus sp.))
F: species
G: birds (aka aves)
H: mus <subgenus> (mus (aka mus <subgenus>))
I: mammals (aka mammalia)
J: eastern european house mouse (aka mus musculus musculus)
K: None of the above. | [C; B] |
<Instruct>: Given the context 'RESULTS AND DISCUSSION Potential cytotoxic activity of synthesized fused isoxazolines 1 and 2 was tested in vitro on four monolayer tumor cell lines: MG-22A (mouse hepatoma), HT-1080 (human fibroblastoma), B16 (mouse melanoma), Neuro 2A (mouse neiroblastoma).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse; human]
<Options>: A: birds (aka aves)
B: mammals (aka mammalia)
C: homo (humans) (aka homo)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: species
F: mus cricetus (aka cricetus cricetus)
G: eastern european house mouse (aka mus musculus musculus)
H: mus sp. (mice (aka mus sp.))
I: human (aka homo sapiens)
J: None of the above. | [J; I] |
<Instruct>: Given the context 'RESULTS AND DISCUSSION Potential cytotoxic activity of synthesized fused isoxazolines 1 and 2 was tested in vitro on four monolayer tumor cell lines: MG-22A (mouse hepatoma), HT-1080 (human fibroblastoma), B16 (mouse melanoma), Neuro 2A (mouse neiroblastoma).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse; human]
<Options>: A: avian (aka aves)
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: mus musculus (house mouse) (aka mus musculus)
D: mus molossinus (aka mus musculus molossinus)
E: mus sp. (mice (aka mus sp.))
F: genus
G: primate (aka primates)
H: humans (aka homo)
I: human (aka homo sapiens)
J: mus <genus> (mice (aka mus <genus>))
K: None of the above. | [C; I] |
<Instruct>: Given the context 'Introduction
Since the early 1970s, the human major histocompatibility complex (MHC) has been shown to be associated with a number of autoimmune, inflammatory, and infectious diseases, and it continues to be the focus of intense research [1].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: homo sapiens (human) (aka homo sapiens)
B: this
C: suborder
D: species
E: macrobiotus sapiens
F: None of the above. | [A] |
<Instruct>: Given the context 'The classical class I and class II loci encode the human leucocyte antigen (HLA) proteins involved in antigen presentation to T cells, initiating the adaptive immune response.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: genus
B: macrobiotus sapiens
C: probles
D: human (aka homo sapiens)
E: animals (aka metazoa)
F: None of the above. | [D] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: homo (humans) (aka homo)
B: menoidium
C: humans (aka homo)
D: genus
E: mouse (aka mus musculus)
F: china
G: homo sapiens (human) (aka homo sapiens)
H: menetes
I: mus (aka mus <subgenus>) (aka mus <subgenus>)
J: menevia
K: menella
L: chicken (aka gallus gallus)
M: avian (aka aves)
N: menesia
O: None of the above. | [G; G; G] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: genus
B: menoidium
C: menosira
D: china
E: infraclass
F: mus (aka mus <subgenus>) (aka mus <subgenus>)
G: gallus
H: mus (aka mus <genus>) (aka mus <genus>)
I: menura
J: birds (aka aves)
K: menetes
L: menida
M: human (aka homo sapiens)
N: None of the above. | [M; M; M] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: birds (aka aves)
B: menetes
C: menoidium
D: menura
E: genus
F: infraclass
G: mus (aka mus <genus>) (aka mus <genus>)
H: gallus
I: china
J: mus (aka mus <subgenus>) (aka mus <subgenus>)
K: menosira
L: menida
M: None of the above. | [M; M; M] |
<Instruct>: Given the context 'Systemic lupus erythematosus (SLE/lupus, [Online Mendelian Inheritance in Man 152700, http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&TabCmd=Limits]) is a chronic, multi-system autoimmune disease affecting young women ten times more commonly than men.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man; women; men]
<Options>: A: this
B: meneristes
C: menetus
D: infraclass
E: probles
F: menevia
G: menetes
H: menella
I: mammals (aka mammalia)
J: mus (aka mus <subgenus>) (aka mus <subgenus>)
K: birds (aka aves)
L: human (aka homo sapiens)
M: mouse (aka mus musculus)
N: None of the above. | [L; L; L] |
<Instruct>: Given the context 'A role for another class III gene, tumour necrosis factor alpha (TNF), in SLE was suggested following the observation that the lupus-prone New Zealand F1 mouse hybrid exhibits constitutively low TNF expression [10].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus molossinus (aka mus musculus molossinus)
B: mus sp. (mice (aka mus sp.))
C: mus musculus (house mouse) (aka mus musculus)
D: mus domesticus (aka mus musculus domesticus)
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: None of the above. | [C] |
<Instruct>: Given the context 'Recently, the development of antinuclear antibodies in patients treated with TNF antagonists has also stimulated interest in the possible role of TNF in SLE [11–13].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: mus musculus (house mouse) (aka mus musculus)
B: human (aka homo sapiens)
C: this
D: goes
E: genus
F: None of the above. | [B] |
<Instruct>: Given the context 'Murine and human candidate gene studies, together with genome-wide linkage screens, provide further support that multiple genetic loci, including the mouse MHC complex H2 and the human MHC locus, contribute to disease susceptibility [14–17].
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; mouse]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: mus (aka mus <subgenus>) (aka mus <subgenus>)
C: avian (aka aves)
D: house mouse (aka mus musculus)
E: suborder
F: mammals (aka mammalia)
G: western european house mouse (aka mus musculus domesticus)
H: animals (aka metazoa)
I: mus sp. (mice (aka mus sp.))
J: homo sapiens (human) (aka homo sapiens)
K: None of the above. | [J; D] |
<Instruct>: Given the context 'Murine and human candidate gene studies, together with genome-wide linkage screens, provide further support that multiple genetic loci, including the mouse MHC complex H2 and the human MHC locus, contribute to disease susceptibility [14–17].
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; mouse]
<Options>: A: mus sp. (mice (aka mus sp.))
B: avian (aka aves)
C: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
D: mus musculus (house mouse) (aka mus musculus)
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: animals (aka metazoa)
G: human (aka homo sapiens)
H: mus (aka mus <genus>) (aka mus <genus>)
I: kingdom
J: primate (aka primates)
K: None of the above. | [G; D] |
<Instruct>: Given the context 'It should be noted that the human MHC was first associated with SLE in 1971, when studies demonstrated that lupus probands were enriched for the class I alleles HL-A8 (now known as HLA-B8) and HLA-W15 (now known as HLA-B15) when compared with healthy controls [18,19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: suborder
B: placental mammals (aka eutheria)
C: birds (aka aves)
D: homo sapiens (human) (aka homo sapiens)
E: animals (aka metazoa)
F: None of the above. | [D] |
<Instruct>: Given the context 'It should be noted that the human MHC was first associated with SLE in 1971, when studies demonstrated that lupus probands were enriched for the class I alleles HL-A8 (now known as HLA-B8) and HLA-W15 (now known as HLA-B15) when compared with healthy controls [18,19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: animals (aka metazoa)
B: birds (aka aves)
C: suborder
D: placental mammals (aka eutheria)
E: None of the above. | [E] |
<Instruct>: Given the context 'This SNP is located within intron 6 of the class III gene, superkiller viralicidic activity 2-like (Saccharomyces cerevisiae) (SKIV2L), and is located approximately 500 kb telomeric to the HLA-DRB1 gene.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [saccharomyces cerevisiae]
<Options>: A: saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883 (aka saccharomyces cerevisiae)
B: saccharomyces cerevisiae x saccharomyces paradoxus
C: saccharomyces cerevisiae synthetic construct
D: saccharomyces albicans (aka candida albicans)
E: saccharomyces hansenii (aka debaryomyces hansenii)
F: None of the above. | [A] |
<Instruct>: Given the context 'Analysis of these data (Figure 4) suggests the presence of short-range LD around our associated variant, rs419788, in CEPH families, encompassing approximately 40 kb of the genome which includes the five genes: complement factor B (CFB), RD RNA binding protein (RDBP), SKIV2L, dom-3 homolg Z (C. elegans) (DOM3Z), and serine/threonine kinase 19 (STK19), and does not include the complement C4 locus.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [c. elegans]
<Options>: A: elegans subgroup (in: mosquitos)
B: uronema elegans
C: drosophila elegans
D: enyo elegans (aka zodarion elegans)
E: rhabditis elegans (aka caenorhabditis elegans)
F: None of the above. | [E] |
<Instruct>: Given the context 'The function of Dom3z is currently unknown, although the homologous yeast protein binds nuclear exoribonuclease.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces cerevisiae (saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883) (aka saccharomyces cerevisiae)
B: saccharomyces cerevisiae or paradoxus (aka saccharomyces cf. cerevisiae/paradoxus)
C: saccharomyceta
D: saccharomycodes
E: saccharomycotina (budding yeasts & others) (aka saccharomycotina)
F: None of the above. | [A] |
<Instruct>: Given the context 'All study participants are European Caucasian on the basis of grandparental origin.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [participants]
<Options>: A: assessor
B: inquisitor
C: cohort
D: homo sapiens (human) (aka homo sapiens)
E: birds (aka aves)
F: None of the above. | [D] |
<Instruct>: Given the context 'Written consent was obtained from all study participants and ethical approval for this study was obtained from the Multi-Centre Research Ethics Committee (MREC 2 June 1998).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [participants]
<Options>: A: genus
B: human (aka homo sapiens)
C: probles
D: homo (humans) (aka homo)
E: inquisitor
F: None of the above. | [B] |
<Instruct>: Given the context 'Supporting Information
Accession Numbers
The Online Mendelian Inheritance in Man (OMIM, http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim) accession numbers for the genes described in this study are as follows: AGER, 600214; BAT3, 142590; C4A, 120810; C4B, 120820; CFB, 138470; DOM3Z, 605996; DOM3Z, 605996; EHMT2, 604599; HLA-B, 142830; HLA-DPB2, 120290; HLA-DQA1, 146880; HLA-DQB1, 604305; HLA-DRA, 142860; HLA-DRB1, 142857; KIAA1949, 610990; MICA, 600169; NOTCH4, 164951; RDBP, 154040; RDBP, 154040; SKIV2L, 600478; SLC44A4, 606107; STK19, 604977; STK19, 604977; TNF, 191160; and TNXB, 600985.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [man]
<Options>: A: birds (aka aves)
B: human (aka homo sapiens)
C: probles
D: genus
E: mouse (aka mus musculus)
F: None of the above. | [B] |
<Instruct>: Given the context 'Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
Abstract
Background
The presence of ERα is the basis for treating breast cancer patients with targeted molecular therapies that block estrogen stimulation of breast cancer cell division.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: cancer
B: mus <genus> (mice (aka mus <genus>))
C: theraps
D: goes
E: homo sapiens (human) (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'To select patients for the above therapies, currently, the ERα presence in breast cancer tissues is determined in clinical laboratories by microscopically scoring the slides subjected to immunohistochemistry (IHC).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: human (aka homo sapiens)
B: other (aka unidentified)
C: species
D: suborder
E: theraps
F: None of the above. | [A] |
<Instruct>: Given the context 'Background
Breast cancer is the most diagnosed and the second leading cause of cancer deaths for women in the United States striking about 300,000 and killing about 40,000 women a year [1].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [women]
<Options>: A: this
B: probles
C: human (aka homo sapiens)
D: infraclass
E: species
F: None of the above. | [C] |
<Instruct>: Given the context 'Because endogenous estrogens directly promote the growth of breast cancer cells, estrogen deprivation either by inhibiting its biosynthesis (aromatase inhibitors) or blocking estrogen-mediated gene transcription (tamoxifen) through its high affinity receptor, the estrogen receptor alpha (ERα), are the primary lines of therapy for breast cancer patients.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: human (aka homo sapiens)
B: other (aka unidentified)
C: kingdom
D: this
E: subsection
F: None of the above. | [A] |
<Instruct>: Given the context 'Because endogenous estrogens directly promote the growth of breast cancer cells, estrogen deprivation either by inhibiting its biosynthesis (aromatase inhibitors) or blocking estrogen-mediated gene transcription (tamoxifen) through its high affinity receptor, the estrogen receptor alpha (ERα), are the primary lines of therapy for breast cancer patients.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: subsection
B: kingdom
C: other (aka unidentified)
D: this
E: None of the above. | [E] |
<Instruct>: Given the context 'Currently, only those patients who express ERα in their tumors are chosen for aromatase inhibitor or tamoxifen therapies.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: homo (humans) (aka homo)
B: subsection
C: this
D: human (aka homo sapiens)
E: kingdom
F: None of the above. | [D] |
<Instruct>: Given the context 'The patients who express ERα in their tumors have an overall longer cancer-free survival and lower recurrence rates than patients who do not express this receptor [3].
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients]
<Options>: A: other (aka unidentified)
B: human (aka homo sapiens)
C: probles
D: kingdom
E: homo (humans) (aka homo)
F: None of the above. | [B] |
<Instruct>: Given the context 'To predict prognosis and identify patients for the above two anti-estrogen therapies, every breast cancer tissue is currently screened for the presence of ERα before a treatment regimen is selected for any breast cancer patient.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients; patient]
<Options>: A: species
B: cancer
C: suborder
D: mus musculus (house mouse) (aka mus musculus)
E: this
F: theraps
G: goes
H: human (aka homo sapiens)
I: circe
J: None of the above. | [H; H] |
<Instruct>: Given the context 'To predict prognosis and identify patients for the above two anti-estrogen therapies, every breast cancer tissue is currently screened for the presence of ERα before a treatment regimen is selected for any breast cancer patient.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patients; patient]
<Options>: A: cancer
B: genus
C: species
D: goes
E: subsection
F: human (aka homo sapiens)
G: probles
H: circe
I: None of the above. | [F; F] |
<Instruct>: Given the context 'Our rational for establishing a cut off value is that any patient who expresses above the cut off level could be selected as a candidate for anti-estrogen therapies and could be considered to have good prognosis.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patient]
<Options>: A: other (aka unidentified)
B: suborder
C: goes
D: homo sapiens (human) (aka homo sapiens)
E: isolate
F: None of the above. | [D] |
<Instruct>: Given the context 'Based on our data above any patient who has more than 5 × 106 copies per 1010 GAPDH copies in her tumor tissue could be considered positive for ERα, could be selected for anti-estrogen therapies and considered to have good prognosis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [patient]
<Options>: A: kingdom
B: theraps
C: human (aka homo sapiens)
D: this
E: humans (aka homo)
F: None of the above. | [C] |
<Instruct>: Given the context 'Further studies on partially purified calf thymus DNA polymerase a.
Abstract
Attempts to prevent the urea conversion of a 200-230,000 molecular weight DNA polymerase alpha to a 150-170,000 molecular weight form by the inclusion of protease inhibitors have not been successful.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: mus spretus (mus musculus spretus) (aka mus spretus)
B: equus subg. equus (aka equus)
C: bos (cattle) (aka bos)
D: boveria
E: bovine (aka bos taurus)
F: None of the above. | [E] |
<Instruct>: Given the context 'Volume 6 Number 10 1979
Nucleic Acids Research
Further studies on partially purified calf thymus DNA polymerase a Keith McKune and Andrew M.Holmes*
Biochemistry Department, Strathclyde University, The Todd Centre, 31 Taylor Street, Glasgow, G4 ONR, UK
Received I June 1979 ABSTRACT
Attempts to prevent the urea conversion of a 200-230, 000 molecular weight DNA polymerase a to a 150-170, 000 molecular weight form by the
inclusion of protease inhibitors have not been successful.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: bovine (aka bos taurus)
B: sueus
C: bos (cattle) (aka bos)
D: bovidae
E: equine (aka equus caballus)
F: None of the above. | [A] |
<Instruct>: Given the context 'Volume 6 Number 10 1979
Nucleic Acids Research
Further studies on partially purified calf thymus DNA polymerase a Keith McKune and Andrew M.Holmes*
Biochemistry Department, Strathclyde University, The Todd Centre, 31 Taylor Street, Glasgow, G4 ONR, UK
Received I June 1979 ABSTRACT
Attempts to prevent the urea conversion of a 200-230, 000 molecular weight DNA polymerase a to a 150-170, 000 molecular weight form by the
inclusion of protease inhibitors have not been successful.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: bovidae
B: bos (cattle) (aka bos)
C: equine (aka equus caballus)
D: sueus
E: None of the above. | [E] |
<Instruct>: Given the context 'INTRODUCTION
In mammals DNA polymerase a is thought to be the replicative
enzyme, but due to low levels of activity, even in tissues actively making DNA, and to enzyme heterogeneity it has been found difficult to purify
However, small samples of DNA polymerase a have been highly purified
2, 3, 4, 5 from several sources and partially characterised
Heterogeneity has been observed in DNA polymerase a from a var
6 7
iety of sources, including rat liver and spleen , Hela cells, baby hamster
8 9, 10 11
kidney cells , mouse myeloma , Drosophila embryos and calf thymus
1,6, 12, 13 .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse; drosophila; calf]
<Options>: A: fruit fly (aka drosophila melanogaster)
B: equine (aka equus caballus)
C: rats (aka rattus) (aka rattus)
D: melanogaster (aka melanogaster <basidiomycete fungi>)
E: rattus rattoides (aka rattus pyctoris)
F: roof rat (aka rattus rattus)
G: eastern european house mouse (aka mus musculus musculus)
H: flies (aka diptera)
I: fruit flies (aka drosophila <flies,genus>)
J: bos bovis (aka bos taurus)
K: melanogaster group
L: bos (cattle) (aka bos)
M: boveria
N: rats (aka rattus norvegicus) (aka rattus norvegicus)
O: veturius
P: mouse (aka mus <genus>)
Q: rattus norvegicus albus
R: mus cricetus (aka cricetus cricetus)
S: house mouse (aka mus musculus)
T: western european house mouse (aka mus musculus domesticus)
U: None of the above. | [N; S; I; J] |
<Instruct>: Given the context 'INTRODUCTION
In mammals DNA polymerase a is thought to be the replicative
enzyme, but due to low levels of activity, even in tissues actively making DNA, and to enzyme heterogeneity it has been found difficult to purify
However, small samples of DNA polymerase a have been highly purified
2, 3, 4, 5 from several sources and partially characterised
Heterogeneity has been observed in DNA polymerase a from a var
6 7
iety of sources, including rat liver and spleen , Hela cells, baby hamster
8 9, 10 11
kidney cells , mouse myeloma , Drosophila embryos and calf thymus
1,6, 12, 13 .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse; drosophila; calf]
<Options>: A: bovidae
B: bactrocera melanogaster (bactrocera (bactrocera) melanogaster) (aka bactrocera melanogaster)
C: rattus rattoides (aka rattus pyctoris)
D: rattus (rats (aka rattus))
E: house rat (aka rattus rattus)
F: mus (aka mus <subgenus>) (aka mus <subgenus>)
G: drosophila <basidiomycete fungi> (drosophila) (aka drosophila <basidiomycete fungi>)
H: mus molossinus (aka mus musculus molossinus)
I: bos bovis (aka bos taurus)
J: melanogaster (aka melanogaster <flies>)
K: mice (aka mus sp.) (aka mus sp.)
L: rats (aka rattus sp.) (aka rattus sp.)
M: eastern european house mouse (aka mus musculus musculus)
N: brown rat (aka rattus norvegicus)
O: drosophila <flies,genus> (fruit flies) (aka drosophila <flies,genus>)
P: bos (cattle) (aka bos)
Q: equus subg. hemionus (aka equus)
R: fruit fly (aka drosophila melanogaster)
S: mus musculus (house mouse) (aka mus musculus)
T: gallus
U: None of the above. | [N; S; O; I] |
<Instruct>: Given the context 'INTRODUCTION
In mammals DNA polymerase a is thought to be the replicative
enzyme, but due to low levels of activity, even in tissues actively making DNA, and to enzyme heterogeneity it has been found difficult to purify
However, small samples of DNA polymerase a have been highly purified
2, 3, 4, 5 from several sources and partially characterised
Heterogeneity has been observed in DNA polymerase a from a var
6 7
iety of sources, including rat liver and spleen , Hela cells, baby hamster
8 9, 10 11
kidney cells , mouse myeloma , Drosophila embryos and calf thymus
1,6, 12, 13 .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse; drosophila; calf]
<Options>: A: mus sp. (mice (aka mus sp.))
B: mus <subgenus> (mus (aka mus <subgenus>))
C: rattus sp. (rats (aka rattus sp.))
D: peromyscus
E: veturius
F: mus molossinus (aka mus musculus molossinus)
G: drosophila (aka drosophila <flies,subgenus>)
H: melanogaster group
I: rattus rattoides (aka rattus rattus)
J: bovidae
K: house mouse (aka mus musculus)
L: horse (aka equus caballus)
M: gallus
N: rattus rattoides (aka rattus pyctoris)
O: melanogaster <basidiomycete fungi> (melanogaster) (aka melanogaster <basidiomycete fungi>)
P: rats (aka rattus norvegicus) (aka rattus norvegicus)
Q: drosophila (aka drosophila <flies,genus>)
R: hawaiian drosophila
S: domestic cow (aka bos taurus)
T: rat (aka rattus) (aka rattus)
U: None of the above. | [P; K; Q; S] |
<Instruct>: Given the context 'INTRODUCTION
In mammals DNA polymerase a is thought to be the replicative
enzyme, but due to low levels of activity, even in tissues actively making DNA, and to enzyme heterogeneity it has been found difficult to purify
However, small samples of DNA polymerase a have been highly purified
2, 3, 4, 5 from several sources and partially characterised
Heterogeneity has been observed in DNA polymerase a from a var
6 7
iety of sources, including rat liver and spleen , Hela cells, baby hamster
8 9, 10 11
kidney cells , mouse myeloma , Drosophila embryos and calf thymus
1,6, 12, 13 .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse; drosophila; calf]
<Options>: A: bovine (aka bos taurus)
B: house rat (aka rattus rattus)
C: mus spretus (mus musculus spretus) (aka mus spretus)
D: norway rat (aka rattus norvegicus)
E: drosophila <basidiomycete fungi> (drosophila) (aka drosophila <basidiomycete fungi>)
F: rattus (rats (aka rattus))
G: mus (aka mus <genus>) (aka mus <genus>)
H: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
I: mus <subgenus> (mus (aka mus <subgenus>))
J: horse (aka equus caballus)
K: rats (aka rattus sp.) (aka rattus sp.)
L: eastern european house mouse (aka mus musculus musculus)
M: melanogaster <basidiomycete fungi> (melanogaster) (aka melanogaster <basidiomycete fungi>)
N: drosophila <flies,subgenus> (drosophila) (aka drosophila <flies,subgenus>)
O: bovidae
P: mouse (aka mus musculus)
Q: gallus
R: fruit fly (aka drosophila melanogaster)
S: fruit fly (aka drosophila <flies,genus>)
T: mus cricetus (aka cricetus cricetus)
U: None of the above. | [D; P; S; A] |
<Instruct>: Given the context 'We have previously observed several species of calf thymus
DNA polymerase a differing in size and charge .', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf]
<Options>: A: equidae (horses) (aka equidae)
B: domestic cow (aka bos taurus)
C: equus subg. equus (aka equus)
D: bos (cattle) (aka bos)
E: bovidae
F: None of the above. | [B] |
<Instruct>: Given the context '5S enzymes, analagous to B, have been observed to
C Information Retrieval Limited 1 Falconberg Court London Wl V 5FG England
3341
Nucleic Acids Research
arise as the result of proteolytic action ' , similarly the B enzyme above 14
,but the relationship of the other observed species is not clear, nor is
the problem of which, if any, of these species is the replicative enzyme,
although circumstantial evidence has implicated a DNA polymerase a to be
15 the replicative enzyme in adenovirus infected KB cells
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [adenovirus]
<Options>: A: adenovirus sp.
B: adenoviridae
C: human adenovirus sp. (human adenovirus) (aka human adenovirus sp.)
D: adenovirus (aka unidentified adenovirus)
E: adomaviridae (aka adomaviruses)
F: None of the above. | [D] |
<Instruct>: Given the context 'MATERIALS AND METHODS
Calf thymus was obtained from 10-16 week old calves and frozen at
-20?C until required.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf; calves]
<Options>: A: bos bubalis (aka bubalus bubalis)
B: bos (cattle) (aka bos)
C: bos taurus indicus (aka bos indicus)
D: equus subg. equus (aka equus)
E: sueus
F: boveria
G: bovidae
H: domestic cow (aka bos taurus)
I: None of the above. | [H; H] |
<Instruct>: Given the context 'MATERIALS AND METHODS
Calf thymus was obtained from 10-16 week old calves and frozen at
-20?C until required.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf; calves]
<Options>: A: sueus
B: bovidae
C: equus subg. equus (aka equus)
D: bos (cattle) (aka bos)
E: bos taurus indicus (aka bos indicus)
F: bos bubalis (aka bubalus bubalis)
G: boveria
H: None of the above. | [H; H] |
<Instruct>: Given the context 'MATERIALS AND METHODS
Calf thymus was obtained from 10-16 week old calves and frozen at
-20?C until required.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [calf; calves]
<Options>: A: equus subg. hemionus (aka equus)
B: veturius
C: bovidae
D: bos taurus indicus (aka bos indicus)
E: bos (cattle) (aka bos)
F: horses (aka equidae)
G: bos bovis (aka bos taurus)
H: boveria
I: None of the above. | [G; G] |
<Instruct>: Given the context '5 p.g bovine serum albumin, 1 ,ug template-initiator complex, enzyme protein and the relevant [ H] deoxynucleoside triphosphate at 0.1 mM and 12-15 cpm/pmol.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bovine]
<Options>: A: bos bubalis (aka bubalus bubalis)
B: bos sp.
C: bos (cattle) (aka bos)
D: boveria
E: cow (aka bos taurus) (aka bos taurus)
F: None of the above. | [E] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.